Experience

National Patient Advocate Foundation

• Non-profit Organizations
• 1 - 100 Employee

• Executive Vice President of Federal Government Relations

  • Sep 2012 - Present

  Directs the organization's federal legislative and regulatory affairs staffs in monitoring, analyzing and responding to key policies relevant to patients' access to health care.

• EVP, Government Relations

  • 2012 - 2013



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Director, Federal Government Relations

  • Jan 1994 - May 2012

  Retired from Pfizer, as of May 2012. Extended exclusivity period for major product by drafting and advocating report language. Drafted and submitted comments to Administration to enhance company status as industry leader in supply chain security. Led company contingent in meeting to update CMS to on clinical study program. Blocked adverse legislation by arranging Hill briefings on dangers of drug importation. Started coalition that educated Congress about outsourcing protection incentives. Represented company in coalition that blocked adverse patent legislation and successfully advocated favorable legislation. Show less

• Director, Federal Government Relations

  • 2002 - 2009

  Avoided adverse legislation by prepping company physician to testify successfully on SSRI antidepressants. Arranged FDA meeting for company officials to educate agency about safety priority of new corporate generic business. Through numerous meetings with Global Security personnel, persuaded Congress about dangers of overseas and internet drug sources. Protected domestic market by leading company participation in GAO study that showed dangers of international drug trade.



FDC Reports/Elsevier

• Congressional News Editor

  • 1984 - 1993

  Wrote and edited news articles on legislation affecting the pharmaceutical industry. Cultivated and maintained sources with congressional personnel, particularly those on committees with primary jurisdiction: Energy & Commerce, Ways & Means, Finance, and Health Education Labor & Pensions. Cultivated and maintained industry sources to judge impact of potential legislation. Wrote and edited news articles on legislation affecting the pharmaceutical industry. Cultivated and maintained sources with congressional personnel, particularly those on committees with primary jurisdiction: Energy & Commerce, Ways & Means, Finance, and Health Education Labor & Pensions. Cultivated and maintained industry sources to judge impact of potential legislation.



F-D-C Reports

• FDA News Editor

  • 1979 - 1983

  Wrote and edited news articles on FDA regulations and their impact on the pharmaceutical industry. Reported on FDA advisory committee meetings and deliberations on clinical trials and scientific/medical issues. Cultivated and maintained sources at the agency and regulated industry. Wrote and edited news articles on FDA regulations and their impact on the pharmaceutical industry. Reported on FDA advisory committee meetings and deliberations on clinical trials and scientific/medical issues. Cultivated and maintained sources at the agency and regulated industry.